Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Protection of normal tissue against late radiation injury by WR-2721. [/sup 60/Co; rats]

Journal Article · · Radiat. Res.; (United States)
DOI:https://doi.org/10.2307/3575574· OSTI ID:6567145
The ability of WR-2721 to protect against late radiation damage has been studied in skin, muscle, and vascular tissues of rats. Animals treated with and without WR-2721 received irradiation to the left hind limb; representative groups were killed at intervals ranging from 72 h to 6 months. Comparison of all drug-treated and non-drug-treated animals showed significant protection (P = less than or equal to 0.05). The time pattern of injury in non-drug-treated rats was biphasic, with significant damage occurring at 72 h and 1 week, returning to normal between 1 and 3 months, but showing significant late damage at 6 months (P = less than or equal to 0.001). Again, this injury pattern did not appear in WR-2721-treated rats. Thus the ability of WR-2721 to protect against acute and chronic radiation injury in vessels, skin, and muscle indicates that an increased therapeutic gain can be expected when this drug is used in clinical radiation therapy.
OSTI ID:
6567145
Journal Information:
Radiat. Res.; (United States), Journal Name: Radiat. Res.; (United States) Vol. 85:2; ISSN RAREA
Country of Publication:
United States
Language:
English

Similar Records

Determination of the radioprotective effects of topical applications of MEA, WR-2721, and N-acetylcysteine on murine skin
Journal Article · Fri Dec 31 23:00:00 EST 1982 · Radiat. Res.; (United States) · OSTI ID:5992161

Late functional and biochemical changes in mouse lung after irradiation: differential effects of WR-2721
Journal Article · Thu Aug 01 00:00:00 EDT 1985 · Radiat. Res.; (United States) · OSTI ID:5197830

Protection from radiation nephropathy by WR-2721
Journal Article · Tue Jan 31 23:00:00 EST 1984 · Radiat. Res.; (United States) · OSTI ID:5126241